BIO RAD LABORATORIES INC
S-8, 1994-04-29
LABORATORY ANALYTICAL INSTRUMENTS
Previous: BECTON DICKINSON & CO, S-8, 1994-04-29
Next: BIO RAD LABORATORIES INC, S-8, 1994-04-29




 <PAGE>

   As filed with the Securities and Exchange Commission on April 28, 1994

                                                          Registration No. ____


                      SECURITIES AND EXCHANGE COMMISSION
                      Washington, D.C.  20549
                            ____________
                              Form S-8
                       REGISTRATION STATEMENT
                               Under
                     THE SECURITIES ACT OF 1933
                             __________

                      BIO-RAD LABORATORIES, INC.
           (Exact name of Registrant as specified in its charter)


               Delaware                                     94-1381833
         (State or Other Jurisdiction                    (I.R.S. Employer
            of Incorporation or                            Identification
              Organization)                                   Number)


                               1000 Alfred Nobel Drive
                             Hercules, California  94547
                      (Address of principal executive offices)
                                  ______________

         BIO-RAD LABORATORIES, INC. AMENDED 1988 EMPLOYEE STOCK PURCHASE PLAN
                                 (Full title of the plan)
                                                         Copy to:

           SANFORD S. WADLER                 CHRISTOPHER L. KAUFMAN, ESQ.
        General Counsel and Secretary             Latham & Watkins
         Bio-Rad Laboratories, Inc.         505 Montgomery Street, Suite 1900
          1000 Alfred Nobel Drive           San Francisco, California  94111
        Hercules, California  94547                (415) 391-0600
            (510) 724-7000
        (Name, address, including zip code,
     and telephone number including area code,
              of agent for service)
                                      _______________


                              CALCULATION OF REGISTRATION FEE
 <TABLE>
 <CAPTION>
                                     Proposed      Proposed
 Title of            Amount to       maximum       maximum
 securities          Amount          offering      aggregate      Amount of
 to be               to be           price per     offering       registration
 registered          registered      share (1)     price (1)      fee
 --------------      -----------     ---------     ---------      ------------
 <S>                 <C>             <C>           <C>            <C>
 Class A Common
  Stock, $1.00
  par value          130,000         $14.31        $1,860,300     $641.48
 </TABLE>


 [FN]
 (1)Estimated solely for the purposes of calculating the amount of the
 registration fee pursuant to Rule 457(h) and (c).  The Proposed
 Maximum Offering Price Per Share is based upon the average of the high
 and low prices for the Company's Common Stock on the American Stock
 Exchange on April 25, 1994.


 <PAGE>

 PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

                      REGISTRATION OF ADDITIONAL SECURITIES


          By Registration Statements on Form S-8 filed with the Securities and
 Exchange Commission on November 16, 1988, and September 4, 1992, Registration
 File No. 33-25583 and 33-51928, respectively, (the "Prior Registration
 Statements"), Bio-Rad Laboratories, Inc., a Delaware corporation (the
 "Company"), previously registered 300,000 shares of the Class A Common Stock,
 par value $1.00 per share (the "Common Stock"), of the Company reserved for
 issuance from time to time in connection with the Bio-Rad Laboratories Amended
 1988 Employee Stock Purchase Plan, (the "Plan").  The Plan  has been further
 amended and the number of shares of Common Stock issuable thereunder has been
 increased to 430,000.  Under this Registration Statement, the Company is
 registering the additional 130,000 shares of Common Stock issuable under the
 Plan.  The contents of the Prior Registration Statements are incorporated by
 reference herein.


 Item 5.  Interests of Named Experts and Counsel

          The legality of the shares of Common Stock offered hereby are being
          passed upon for the Company by Sanford S. Wadler, General Counsel and
          Secretary of the Company.


 Item 8.  Exhibits

     4.1  Bio-Rad Laboratories, Inc. Amended 1988 Employee Stock Purchase Plan

     5.1  Opinion of Sanford S. Wadler, General Counsel and Secretary of the
          Company

     23.1 Consent of Independent Public Accountants.

     23.2 Consent of Sanford S. Wadler, General Counsel and Secretary of the
          Company (included in Exhibit 5.1).

     24   Power of Attorney (incorporated in the signature page to the
          Registration Statement--see pages 2 and 3).



                                       1.


 <PAGE>

                                   SIGNATURES

             Pursuant to the requirements of the Securities Act of 1993, as
 amended, the registrant certifies that it has reasonable grounds to believe
 that it meets all of the requirements for filing on Form S-8 and has duly
 caused this Registration Statement to be signed on its behalf by the
 undersigned, thereunto duly authorized, in the city of Hercules, California on
 April 28, 1994.
                                     BIO-RAD LABORATORIES, INC.

                                     By:   /s/ Sanford S. Wadler
                                           Name:   Sanford S. Wadler
                                           Title:  General Counsel and Secretary


 POWER OF ATTORNEY

             KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
 appears below, hereby constitutes and appoints David Schwartz and Thomas L.
 Braje and each acting alone, his true and lawful attorneys-in-fact and agents,
 with full power of substitution and resubstitution, for him and in his name,
 place and stead, in any and all capacities, to sign any or all amendments or
 supplements to this Registration Statement and to file the same with all
 exhibits thereto and other documents in connection therewith, with the
 Securities and Exchange Commission, granting unto said attorneys-in-fact and
 agents full power and authority to do and perform each and every act and thing
 necessary or appropriate to be done with respect to this Registration Statement
 or any amendments or supplements hereto in and about the premises, as fully to
 all intents and purposes as he might or could do in person, hereby ratifying
 and confirming all that said attorneys-in-fact and agents, each acting alone,
 or his substitute or substitutes, may lawfully do or cause to be done by virtue
 hereof.

             Pursuant to the requirements of the Securities Act of  1933, as
 amended, this Registration Statement has been signed by the following persons
 in their respective capacities with Bio-Rad Laboratories, Inc. and on the dates
 indicated.


                                        2.



 <PAGE>


 Signature                     Title                     Date


                               President                 April 28, 1994
 /s/ David Schwartz            and Director
 David Schwartz


 /s/ James J. Bennett          Director                  April 28, 1994
 James J. Bennett


 /s/ Albert J. Hillman         Director                  April 28, 1994
 Albert J. Hillman


 /s/ Philip L. Padou           Director                  April 28, 1994
 Philip L. Padou


 /s/ Alice N. Schwartz         Director                  April 28, 1994
 Alice N. Schwartz


 /s/ Burton A. Zabin           Director                  April 28, 1994
 Burton A. Zabin


                               Vice President,           April 28, 1994
 /s/ Thomas L. Braje           Chief Financial Officer
 Thomas L. Braje

                               Principal Accounting      April 28, 1994
 /s/ James R. Stark            Officer
 James R. Stark



                                        3.




 <PAGE>

                          INDEX TO EXHIBITS



 EXHIBIT                                                     PAGE

 4.1  Bio-Rad Laboratories, Inc. Amended 1988
         Employee Stock Purchase Plan  . . . . . . . . . . .   7

 5.1   Opinion of Sanford S. Wadler, General Counsel
         and Secretary of the Company  . . . . . . . . . . .   5

 23.1  Consent of Independent Public Accountants . . . . . .   6

 23.2  Consent of Sanford S. Wadler, General Counsel
         and Secretary of the Company (included in Exhibit 5.1)

 24    Power of Attorney (incorporated in the signature page
         to the Registration Statement (see pp. 2 and 3)




                                       4.



 <PAGE>

                                                                    Exhibit 5.1

                                 April 28, 1994


 Bio-Rad Laboratories, Inc.
 1000 Alfred Nobel Drive
 Hercules, California  94547

             Re:  Bio-Rad Laboratories, Inc. Class A Common Stock,
             par value $1.00 per share

 Ladies and Gentlemen:

       I  have   examined  the   Registration  Statement   of  Form  S-8   (the
 "Registration Statement"),  which Bio-Rad  Laboratories, Inc.  (the "Company")
 intends to file with the Securities and Exchange Commission in connection with
 the  registration  under the  Securities  Act  of  1933,  as  amended,  of  an
 additional 130,000 shares  of Class A common stock, par  value $1.00 per share
 (the  "Shares") in connection with the Bio-Rad Laboratories, Inc. Amended 1988
 Employee Stock Purchase Plan (the "Plan").  I am familiar with the Plan.  I am
 familiar with the proceedings undertaken by the Company in connection with the
 issuance of the Shares under  the Plan and the authorization of  such issuance
 thereunder, and have  examined such  documents and such  questions of law  and
 fact as  I have deemed necessary  in order to express  the opinion hereinafter
 stated.

       Based  on the foregoing, I  am of the opinion that  the Shares have been
 duly authorized, and upon  issuance of the Shares under the  terms of the Plan
 and delivery  and payment  therefor of  legal consideration  in excess  of the
 aggregate par value of the Shares  issued, such Shares will be validly issued,
 fully paid and nonassessable.

       I hereby  consent to the  filing of this  opinion as  an exhibit to  the
 Registration Statement and to the reference to me under the heading "Interests
 of  Named Experts  and  Counsel"  contained in  Part  II  of the  Registration
 Statement.

             Very truly yours,

             /s/ Sanford S. Wadler

             Sanford S. Wadler
             General Counsel and Secretary



                                       5.



 <PAGE>

                                                                   Exhibit 23.1

                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

       As independent public accountants, we hereby consent to the
 incorporation by reference in this Registration Statement of our reports dated
 February 18, 1994, included in Bio-Rad Laboratories, Inc.'s Form 10-K for the
 year ended December 31,1993.



                                              /s/ Arthur Andersen & Co.

 ARTHUR ANDERSEN & CO.

 San Francisco, California,
   April 28, 1994






                                       6.




 <PAGE>

                                                                    Exhibit 4.1




                           BIO-RAD LABORATORIES, INC.

                    AMENDED 1988 EMPLOYEE STOCK PURCHASE PLAN



       1.    Purpose

             The Bio-Rad Laboratories, Inc., Amended 1988 Stock Purchase Plan
 (the "Plan") is designed to encourage and assist employees of Bio-Rad
 Laboratories, Inc. (the "Company") to acquire an equity interest in the
 Company through the purchase of shares of Common Stock.

       2.    Administration

             The Plan shall be administered by the Board of Directors (or a
 committee of two or more directors, each of whom is a "disinterested person"
 as defined by Rule 16b-3 under the Securities Exchange Act of 1934, as amended
 (the "Exchange Act"), which in either case is referred to as the "Board") in
 accordance with Rule 16b-3.  Such committee or such other persons (who need
 not be directors) as the Board may from time to time select (the
 "Administrator"), shall be responsible for any matters for which
 "disinterested administration" is not required by Rule 16b-3.  Subject to the
 express provisions of the Plan, the overall supervision of the Board  and to
 the limitations of Section 423 or any successor provision of the Internal
 Revenue Code of 1986, as amended, the Administrator may administer and
 interpret the Plan in any manner it believes to be desirable, and any such
 interpretation shall be conclusive and binding on the Company and all
 participants.

       3.    Number of Shares

             The Company has reserved for sale under the Plan 300,000 shares of
 Common Stock.  430,000 shares may be sold under the Plan of which 300,000
 shares may be newly issued shares and 130,000 shares may be reacquired in
 private transactions or open market purchases.

             In the event of any reorganization, recapitalization, stock split,
 reverse stock split, stock dividend, combination of shares, merger,
 consolidation, offering of rights or other similar change in the capital
 structure of the Company, the Administrator may make such adjustment, if any,
 as it deems appropriate in the number, kind and purchase price of the shares
 available for purchase under the Plan and in the maximum number of shares
 subject to any option under the Plan.

       4.    Eligibility Requirements

             Each employee, except those described in the next paragraph, shall
 become eligible to participate in the Plan in accordance with Section 5 on the


                                       7



 <PAGE>

 first Enrollment Date following six months of employment by the Company.
 Participation in the Plan is entirely voluntary.

             The following employees are not eligible to participate in the
 Plan:

             (i) employees who would, immediately upon enrollment in the Plan,
 own directly or indirectly, or hold options or rights to acquire, an aggregate
 of 5% or more of the total combined voting power or value of all outstanding
 shares of all classes of the Company or any subsidiary;

             (ii) employees who are customarily employed by the Company less
 than 20 hours per week or less than five months in any calendar year; and

             (iii) employees who are prohibited by the laws of the nation of
 their residence or employment from participating in the Plan.

 Employees who are also directors or "officers" of the Company (as defined in
 Rule 16a-1(f) under the Exchange Act, as such rule may be amended in the
 future) may participate only in accordance with Rule 16b-3.  The Plan is
 intended to conform to the extent necessary with all provisions of the
 Securities Act of 1933, as amended, and the Exchange Act and any and all
 regulations and rules promulgated by the Securities and Exchange Commission
 thereunder, including, without limitation, Rule 16b-3.  Notwithstanding
 anything herein to the contrary, the Plan shall be administered, and the
 options shall be granted and may be exercised, only in such a manner as to
 conform to such laws, rules and regulations.  To the extent permitted by
 applicable law, the Plan and the options granted hereunder shall be deemed
 amended to the extent necessary to conform to such laws, rules and
 regulations.  Officer and director participants should be aware of the
 following restrictions which may be imposed by the provisions of Rule 16b-
 3(d)(2)(i):  (1)  officer and director participants must hold the Common Stock
 at least six months from the Purchase Date (as defined herein) and (ii)
 officer or director participants who cease participation in the Plan may not
 participate again for at least six months.

             "Employee" shall mean any individual who performs services for the
 Company pursuant to an employment relationship described in Treasury
 Regulations Section 31.3401(c)-1 or any successor provision.  "Subsidiary"
 shall mean any corporation in an unbroken chain of corporations beginning with
 the Company if, as of the applicable Enrollment Date, each of the corporations
 other than the last corporation in the chain owns stock possessing 50% or more
 of the total combined voting power of all classes of stock in one of the other
 corporations in the chain.  "Participating subsidiary" shall mean a subsidiary
 which has been designated by the Administrator as covered by the Plan.

       5.    Enrollment

             Any eligible employee may enroll or re-enroll in the Plan as of
 the first trading day of any three month, six month, or other period as shall
 be established by the Administrator from time to time, or such other specific
 trading days established by the Administrator from time to time ("Enrollment

                                       8




 <PAGE>

 Dates").  In order to enroll or re-enroll, an eligible employee must complete,
 sign and submit to the Company an enrollment form.  Any enrollment form
 received by the Company before the 10th day of the month preceding an
 Enrollment Date, or such other date established by the Administrator from time
 to time ("Cut-Off Date"), will be effective on that Enrollment Date.

       6.    Grant of Options on Enrollment

             Enrollment by a participant in the Plan on an Enrollment Date will
 constitute the grant by the Company to the participant of options to purchase
 shares of Common Stock from the Company under the Plan.  Re-enrollment by a
 participant in the Plan will constitute cancellation by the participant of one
 or more outstanding options and the grant by the Company to the participant of
 new options (equal in number to the number of options cancelled) on the
 Enrollment Date on which such re-enrollment occurs.  An increase (but not a
 decrease) in the level of payroll withholding also constitutes the grant of
 new options for the incremental change in the percentage withheld but does not
 cancel outstanding options.  Any participant whose options expire and who has
 not withdrawn from the Plan will automatically be re-enrolled in the Plan and
 granted new options (equal in number to the number of expiring options) on the
 Enrollment Date immediately following the Purchase Date on which his then
 current options expire.  Any date on which a participant is granted options
 under the Plan is referred to as a "Grant Date".

             Each option granted under the Plan shall have the following terms:
             (i) whether or not all shares have been purchased thereunder, the
 option will expire on the earliest to occur of (A) the completion of the
 purchase of shares on the last Purchase Date occurring within 27 months of the
 Grant Date for such option, or such shorter option period as may be
 established by the Board from time to time prior to an Enrollment Date for all
 options to be granted on such Enrollment Date, or (B) the date on which
 participation of such participant in the Plan terminates for any reason;

             (ii) payment for shares purchased under the option will be made
 only through payroll withholding in accordance with Section 7;

             (iii) purchase of shares upon exercise of the option will be
 accomplished only in installments in accordance with Section 8;

             (iv) the price per share under the option will be determined as
 provided in Section 8;

             (v) the number of shares available for purchase under each option
 will be established by the Board from time to time prior to an Enrollment Date
 for all options to be granted on such Enrollment Date;

             (vi) notwithstanding clause (v), the option (taken together with
 all other options then outstanding under this Plan and under all other similar
 stock purchase plans of the Company or any subsidiary) will in no event give
 the participant the right to purchase shares at a rate which accrues in excess
 of $25,000 of fair market value of such shares (less the fair market value of
 any shares previously purchased during such year under options which have

                                       9




 <PAGE>

 expired or terminated) determined at the applicable Grant Dates in any
 calendar year during which such participant is enrolled in the Plan at any
 time; and

             (vii) the option will in all respects be subject to the terms and
 conditions of the Plan, as interpreted by the Administrator from time to time.

       7.    Payroll Withholding

             Each participant may elect to make contributions at a monthly rate
 equal to any whole percentage up to a maximum of 10%, or such other maximum
 percentage as the Board may establish from time to time before an Enrollment
 Date for all options to be granted on such Enrollment Date, of his or her
 monthly base earnings.  Monthly base earnings exclude bonuses, overtime pay,
 shift premiums, long-term disability or workers compensation payments and
 similar amounts, but includes elective qualified contributions by the
 participant to employee benefit plans.  The rate of contribution shall be
 designated by the participant in the enrollment form.  A participant may elect
 to increase or decrease the rate of contribution effective as of any
 Enrollment Date by delivery to the Company not later than the related Cutoff
 Date of a new enrollment form indicating the revised rate of contribution. An
 increase (but not a decrease) in the contribution rate constitutes the grant
 of new options.  If the rate is decreased and there is more than one option
 outstanding, the participant may specify the option to which such decrease
 should apply.

             Contributions shall be credited to a participant's account as soon
 as administratively feasible after payroll withholding.  The Company shall be
 entitled to use of the contributions immediately after payroll withholding and
 shall have no obligation to pay interest on the contributions to any
 participant.

       8.    Purchase of Shares

             On the last trading day of each March, June, September and
 December, or on such other specific trading days as may be established by the
 Board from time to time prior to an Enrollment Date for all options to be
 granted on such Enrollment Date ("Purchase Dates") the Company shall apply the
 funds then credited to each participant's account to the purchase of whole
 shares of Common Stock.  The cost to the participant for the shares purchased
 under any option shall be 85% of the lower of:

             (i) the fair market value on the Grant Date for such option; or

             (ii) the fair market value on the Purchase Date.

             For the purposes of the Plan, the "fair market value" of the
 Common Stock on a date shall be (a) the closing price of Common Stock on such
 date on any established stock exchange if the Common Stock is traded on such
 an exchange, (b) the mean between the high bid and low asked quotations for
 the Common Stock on such date as quoted on the National Association of
 Securities Dealers Automated Quotation System, as reported in the Wall Street

                                       10




 <PAGE>

 Journal or similar publication if such prices are so quoted or reported (if
 such date is not a trading day, the average of such quotations on the last
 preceding trading day shall be used in lieu of such quotations), or (c) the
 fair market value on such date as determined by the Administrator if shares of
 Common Stock are not so listed, quoted or reported.

             At the election of the participant, certificates evidencing shares
 purchased on any Purchase Date shall be delivered as soon as administratively
 feasible; provided, however, the Administrator may, from time to time,
 establish limitations as to the frequency with which a participant may elect
 to have certificates evidencing shares delivered hereunder.  Participants
 shall be treated as the owners of their shares effective as of the Purchase
 Date.  Any cash equal to less than the price of a whole share of Common Stock
 left in a participant's payroll deduction account on a Purchase Date shall be
 carried forward in such participant's account for application on the next
 Purchase Date.

             The Administrator may in the case of participants employed by
 participating subsidiaries provide for Common Stock to be sold through the
 relevant subsidiaries to such participants, to the extent consistent with
 Section 423 of the Internal Revenue Code.

       9.    Withdrawal From the Plan

             A participant may withdraw from the Plan in full (but not in part)
 at any time upon delivery to the Company of a notice of withdrawal at such
 times as the Administrator may determine from time to time.  If notice is
 received before the applicable Cut-Off Date, all funds credited to a
 participant's payroll deduction account shall be distributed to him without
 interest as soon as administratively feasible after notice of withdrawal is
 received by the Company.  An employee who has withdrawn may not return funds
 to the Company and require the Company to apply those funds to the purchase of
 shares.  Any eligible employee who has withdrawn from the Plan may, however,
 re-enroll in the Plan again on the second subsequent Enrollment Date following
 withdrawal in accordance with the provisions of Section 5.

       10.   Termination of Employment

             Participation in the Plan terminates immediately when a
 participant ceases to be employed by the Company for any reason
 whatsoever (including death or disability) or otherwise becomes ineligible to
 participate in the Plan.  As soon as administratively feasible after
 termination, the Company shall pay to the participant or his or her
 beneficiary, or legal representative, all amounts credited to the
 participant's payroll deduction account.



                                       11



 <PAGE>

       11.   Leave of Absence

             Unless a participant has voluntarily withdrawn from the Plan,
 shares will be purchased for that participant's account on the Purchase Date
 next following commencement of a leave of absence by such participant.
 Participation in the Plan will terminate immediately after the purchase of
 shares on such Purchase Date, however, unless:

             (i) the leave of absence is of less than 90 days duration and is
 due to illness, injury or other reason approved by the Administrator; or

             (ii) the participant's right to reemployment after such leave is
 guaranteed by contract or statute.

       12.   Designation of Beneficiary

             Each participant may designate one or more beneficiaries in the
 event of death and may, in his or her sole discretion, change such designation
 at any time.  Any such designation shall be effective upon receipt by the
 Company and shall control over any disposition by will or otherwise.

             As soon as administratively feasible after the death of a
 participant, amounts credited to his or her account shall be paid in cash to
 the designated beneficiaries or, in the absence of a designation, to the
 executor, administrator or other legal representative of the participant's
 estate.  Such payment shall relieve the Company of further liability with
 respect to the Plan on account of the deceased participant.  If more than one
 beneficiary is designated, each beneficiary shall receive an equal portion of
 the account unless the participant has given express contrary instructions.

       13.   Assignment

             The rights of a participant under the Plan shall not be assignable
 by such participant, by operation of law, or otherwise. No participant may
 create a lien on any funds, securities, rights or other property held by the
 Company for the account of the participant under the Plan, except to the
 extent that there has been a designation of beneficiaries in accordance with
 the Plan, and except to the extent permitted by the laws of descent and
 distribution if beneficiaries have not been designated.  A participant's right
 to purchase shares under the Plan shall be exercisable only during the
 participant's lifetime and only by him or her, except that a participant may
 direct the Company in the enrollment form to issue share certificates to the
 participant jointly with one or more other persons with right of survivorship,
 or to certain forms of trusts approved by the Administrator.

       14.   Administrative Assistance

             If the Administrator in its discretion so elects, it may retain a
 brokerage firm, bank or other financial institution to assist in the purchase
 of shares, delivery of reports or other administrative aspects of the Plan.
 If the Administrator so elects, each participant shall (unless prohibited by
 the laws of the nation of his or her employment or residence) be deemed upon

                                       12



 <PAGE>

 enrollment in the Plan to have authorized the establishment of an account on
 his or her behalf at such institution.  Shares purchased by a participant
 under the Plan shall be held in the account in the participant's name, or if
 the participant so indicates in the enrollment form, in the participant's name
 together with the name of one or more other persons, in joint tenancy with
 right of survivorship or spousal community property, or in certain forms of
 trusts approved by the Administrator.

       15.   Costs

             All costs and expenses incurred in administering the Plan shall be
 paid by the Company, except that any stamp duties or transfer taxes applicable
 to participation in the Plan may be charged to the account of such participant
 by the Company.  Any

 brokerage fees for the purchase of shares by a participant shall be paid by
 the Company.

       16.   Reports

             The Company shall provide or cause to be provided to each
 participant a report of his or her contributions and the shares purchased by
 that participant as of each Purchase Date.

       17.   Equal Rights and Privileges

             All eligible employees shall have equal rights and privileges with
 respect to the Plan so that the Plan qualifies as an "employee stock purchase
 plan" within the meaning of Section 423 or any successor provision of the
 Internal Revenue Code and the related regulations.  Notwithstanding the
 express terms of the Plan, any provision of the Plan which is inconsistent
 with Section 423 or any successor provision of the Internal Revenue Code shall
 without further act or amendment by the Company or the Board be reformed to
 comply with the requirements of Section 423.  This Section 17 shall take
 precedence over all other provisions in the Plan.

       18.   Applicable Law

             The Plan shall be governed by the substantive laws (excluding the
 conflict of laws rules) of the State of California.

       19.   Modification and Termination

             The Board may amend, alter or terminate the Plan at any time.  No
 amendment shall be effective unless within one year after it is adopted by the
 Board it is approved by the holders of a majority of the voting power of the
 Company's outstanding shares, if such amendment would:

             (i)   increase the number of shares reserved for purchase under
 the Plan;

             (ii)  materially increase the benefits to participants; or

                                       13




 <PAGE>

             (iii) materially modify the requirements for participation;

             (iv)  amend or modify the Plan in a manner requiring stockholder
 approval under Rule 16b-3.

             In the event the Plan is terminated, the Board may elect to
 terminate all outstanding options either prior to expiration or upon
 completion of the purchase of shares on the next Purchase Date, or may elect
 to permit options to expire in accordance with their terms (and participation
 to continue through such expiration dates).  If the options are terminated
 prior to expiration, all funds contributed to the Plan that have not been used
 to purchase shares shall be returned to the participants without interest as
 soon as administratively feasible.

             If at any time the shares available under the Plan are
 overenrolled, enrollments shall be reduced proportionately to eliminate the
 overenrollment.  Any funds that cannot be applied to the purchase of shares
 due to overenrollment shall be refunded to participants as soon as
 administratively feasible.

       20.   No Right of Employment

             Neither the grant nor the exercise of any rights to purchase
 shares under this Plan nor anything in this Plan shall impose upon the Company
 any obligation to employ or continue to employ any participant.  The right of
 the Company to terminate any employee shall not be diminished or affected
 because any rights to purchase shares have been granted to such employee.

       21.   Requirements of Law

             The Company shall not be required to sell, issue, or deliver any
 shares of Common Stock under this Plan if such sale, issuance, or delivery
 might constitute a violation by the Company
 or the participant of any provision of law.  Unless a registration statement
 under the Securities Act of 1933 (the "Act") is in effect with respect to the
 shares of Common Stock proposed to be delivered under the Plan, the Company
 shall not be required to issue such shares if, in the opinion of the Company
 or its counsel, such issuance would violate the Act.  Regardless of whether
 such shares of Common Stock have been registered under the Act or registered
 or qualified under the securities laws of any state, the Company may impose
 restrictions upon the hypothecation or further sale or transfer of such shares
 (including the placement of appropriate legends on stock certificates) if, in
 the judgment of the Company or its counsel, such restrictions are necessary or
 desirable to achieve compliance with the provisions of the Act, the securities
 laws of any state, or any other law or are otherwise in the best interests of
 the Company.  As a condition precedent to the issuance of any shares of Common
 Stock under the Plan, the Company may require evidence satisfactory to it or
 its counsel to the effect that the purchaser of such shares is acquiring the
 shares for investment and not with a view to their distribution.  Any
 determination by the Company or its counsel in connection with any of the
 foregoing shall be final and binding on all parties.


                                       14



 <PAGE>

             If, in the opinion of the Company and its counsel, any legend
 placed on a stock certificate representing shares of Common Stock issued under
 the Plan is no longer required in order to comply with applicable securities
 or other laws, the holder of such certificate shall be entitled to exchange
 such certificate for a certificate representing a like number of shares
 lacking such legend.

             The Company may, but shall not be obligated to, register or
 qualify any securities covered by the Plan.  The Company shall not be
 obligated to take any other affirmative action in order to cause the grant or
 exercise of any right or the issuance, sale, or delivery of shares pursuant to
 the exercise of any right to comply with any law.

       22. Board and Shareholder Approval

             This Plan was originally approved by the Board of Directors on
 March 2, 1988 and by the holders of a majority of the voting power of all
 outstanding shares of the Company on April 26, 1988.  The Plan became
 effective on January 1, 1989.  The Plan was first amended by the Board of
 Directors on January 15, 1992 and by holders of a majority of the voting power
 of all outstanding shares of the Company on April 28, 1992.  The Plan was
 further amended by the Board of Directors on February 2, 1994 and by the
 holders of a majority of the voting power of all outstanding shares of the
 Company on April 26, 1994.





                                       15





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission